Ir.kiorapharma.com

EyeGate Pharma Reports Full Year 2020 Financial Results and …

WEBWALTHAM, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company …

Actived: 3 days ago

URL: https://ir.kiorapharma.com/news-events/press-releases/detail/20/eyegate-pharma-reports-full-year-2020-financial-results-and

EyeGate Addresses Final FDA Action Item with Submission of IDE

WEBResponses to the last of four outstanding action items submitted; Potential to start clinical study in the Third Quarter of 2018. WALTHAM, Mass., June 22, 2018 (GLOBE …

Category:  Health Go Health

EyeGate Pharma Announces Positive Topline Data in Follow-on …

WEBWALTHAM, MA / ACCESSWIRE / March 31, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on …

Category:  Health Go Health

Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing

WEBAmendment eliminates $4.75M in near-term milestones Kiora would have owed to Sentrx; Sentrx gains access to Kiora's recently issued patents covering the …

Category:  Health Go Health

EyeGate Addresses Majority of FDA’s Action Items with …

WEBResponses to three of the four outstanding action items submitted; Response to Fourth action item Expected in the Second Quarter of 2018 with Potential …

Category:  Health Go Health

ir.kiorapharma.com

WEBExhibit 99.1 . EyeGate Pharmaceuticals Announces New Board Member, Steven Boyd . WALTHAM, Mass., May 16, 2018 — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) …

Category:  Health Go Health

EYEGATE PHARMACEUTICALS, INC.

WEBUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K xAnnual report pursuant to Section 13 or 15(d) of the Securities Exchange …

Category:  Health Go Health

EyeGate Receives FDA Feedback on Investigational Device …

WEBFeedback Provides Clear Path to Resubmission; Expected July 2018. WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, …

Category:  Health Go Health

EyeGate Pharmaceuticals Announces New Board Member, Steven …

WEBWALTHAM, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a clinical-stage, specialty …

Category:  Health Go Health

Inherited Retinal Disease Expert, Mark Pennesi, M.D., Ph.D., Joins

WEBEncinitas, California--(Newsfile Corp. - April 21, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Mark Pennesi, M.D., Ph.D., the …

Category:  Health Go Health

EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results …

WEBWALTHAM, MA / ACCESSWIRE / March 1, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') today announced financial results for …

Category:  Health Go Health

EyeGate Pharma Reports First Quarter 2020 Financial Results and

WEBWALTHAM, MA / ACCESSWIRE / May 6, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused …

Category:  Health Go Health

EyeGate Pharma Reports Third Quarter 2019 Financial Results and

WEBWALTHAM, MA / ACCESSWIRE / November 7, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on …

Category:  Health Go Health

EyeGate Pharmaceuticals Announces New Board Member, Peter …

WEBWALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage, specialty …

Category:  Health Go Health

EyeGate Pharma Reports Second Quarter 2019 Financial Results …

WEBWALTHAM, MA / ACCESSWIRE / August 8, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on …

Category:  Health Go Health

ir.kiorapharma.com

WEBInternational Headquarters. 2150 St. Elzéar Blvd. West. Laval, Quebec H7L 4A8 Phone: 514.744.6792 Fax: 514.744.6272 . Contact Information:

Category:  Health Go Health